Supreme Court Decision

The Olympics, natural events and Supreme Court decisions have not only made history this year, they have touched the world of eye care.

On June 28, the U.S. Supreme Court ruled 6-3 in Loper Bright Enterprises v. Raimondo, Secretary of Commerce to overturn a decades-old decision known as the “Chevron deference.”

On June 25, 1984, the Supreme Court settled the case of Chevron U.S.A. Inc. v. Natural Resources Defense Council Inc.

Some women with sexual arousal disorder reported improved sexual function after receiving topical sildenafil cream compared with placebo cream, according to results of a phase 2b study published in Obstetrics & Gynecology.

The U.S. Supreme Court ruled 5-4 on Thursday that members of the Sackler family cannot be protected from future lawsuits for their roles in the opioid epidemic.

In Food and Drug Administration et al v. Alliance for Hippocratic Medicine et al, the Supreme Court ruled in favor of the FDA, preserving access to mifepristone for medication abortion under rules adopted in 2016.

The Supreme Court blocked Purdue Pharma’s bankruptcy proceedings Thursday in a decision that also halts the deal granting immunity to the Sackler family.

The U.S. Supreme Court has ruled 6-3 against President Joe Biden’s proposed student debt relief program, a decision that could impact health care professionals with significant student loans, an expert said.

The American Psychiatric Association released a statement condemning the Supreme Court’s ruling declaring that race cannot be a factor in university admissions. The Supreme Court on June 29 ruled 6-3 that admissions programs at Harvard University and the University of North Carolina-Chapel Hill that relied partly on race considerations were unconstitutional.

The U.S. Supreme Court ruled against the use of affirmative action programs during admissions processes at colleges and universities, potentially reducing the number of underrepresented students in medical education, experts said.